Skip to main content

ephedrine

Generic: EPHEDRINE SULFATE·Brand: AKOVAZ, CORPHEDRA, EMERPHED, EPHEDRINE SULFATE, Emerphed, REZIPRES

ephedrine: developed by 1 company · 1 clinical trial tracked · 1 FDA decision.

ephedrine evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect ephedrine to NEXS; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could ephedrine → NEXS affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Postpartum Hemorrhage

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (2)
CompanyPhase
NEXUS BIOPHARMA INC (NEXS)Approved
NEXUS BIOPHARMA INC (NEXS)Approved
Clinical Trials (1)

Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

NCT06285396·N/A
Recruiting

Primary endpoint: Motility index

InterventionalRandomizedopen96 targetStarted 2024-03Completion 2026-121 site · CanadaSamuel Lunenfeld Research Institute, Mount Sinai Hospital
FDA Decisions1 records
Approval1. INDICATIONS AND USAGE EMERPHED and EMERPHED-PFS is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. EMERPHED and EMERPHED-PFS is an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. ( 1 )(NEXS)FDA ↗
NDA213407Type 5 - New Formulation or New ManufacturerStandardIntravenousSolution

Frequently asked questions

Who is developing ephedrine?

ephedrine is being developed by NEXUS BIOPHARMA INC.

How many clinical trials involve ephedrine?

BioSniper tracks 1 clinical trial involving ephedrine.

What is ephedrine's latest FDA decision?

The most recent tracked FDA decision for ephedrine is Approval for 1. INDICATIONS AND USAGE EMERPHED and EMERPHED-PFS is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. EMERPHED and EMERPHED-PFS is an alpha- and beta- adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. ( 1 ), dated April 17, 2020.